These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

787 related items for PubMed ID: 17307447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators.
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [Abstract] [Full Text] [Related]

  • 4. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.
    J Am Coll Cardiol; 2008 Apr 01; 51(13):1247-54. PubMed ID: 18371553
    [Abstract] [Full Text] [Related]

  • 5. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD, Body SC, Shernan SK, Wang S, Mangano DT, Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc, Ischemia Research and Education Foundation (IREF) Investigators.
    J Thorac Cardiovasc Surg; 2006 Aug 01; 132(2):392-400. PubMed ID: 16872968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E.
    J Thorac Cardiovasc Surg; 2005 Aug 01; 130(2):512-9. PubMed ID: 16077421
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 10. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP, Perez de la Hoz R, Brito VM, Duronto E, Dabbous OH, Gore JM, Anderson FA, GRACE Investigators.
    Int J Cardiol; 2007 Jun 25; 119(1):65-72. PubMed ID: 17045681
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U, Melina G, Capuano F, Comito C, Bianchini R, Simon C, Refice S, Angeloni E, Sinatra R.
    J Cardiovasc Med (Hagerstown); 2008 Nov 25; 9(11):1098-103. PubMed ID: 18852580
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
    Kalavrouziotis D, Buth KJ, Cox JL, Baskett RJ.
    Am Heart J; 2011 Nov 25; 162(5):836-43. PubMed ID: 22093199
    [Abstract] [Full Text] [Related]

  • 17. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH, Roe MT, Chen AY, Lytle BL, Pollack CV, Brindis RG, Smith SC, Harrington RA, Fintel D, Fraulo ES, Califf RM, Gibler WB, Ohman EM, Peterson ED.
    Arch Intern Med; 2006 Oct 09; 166(18):2027-34. PubMed ID: 17030838
    [Abstract] [Full Text] [Related]

  • 18. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N, Cambou JP, Hanania G, Kadri Z, Genès N, Lablanche JM, Blanchard D, Vaur L, Clerson P, Guéret P, USIC 2000 investigators.
    Am Heart J; 2005 Dec 09; 150(6):1147-53. PubMed ID: 16338251
    [Abstract] [Full Text] [Related]

  • 19. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
    Völzke H, Kleine V, Robinson DM, Grimm R, Hertwig S, Schwahn C, Eckel L, Rettig R.
    Int J Cardiol; 2005 Jan 09; 98(1):133-9. PubMed ID: 15676177
    [Abstract] [Full Text] [Related]

  • 20. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappé DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study Group.
    Am J Cardiol; 2005 Apr 01; 95(7):827-31. PubMed ID: 15781009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.